B CELL IMMUNOBIOLOGY IN DISEASE: Evolving Concepts from the Clinic
Top Cited Papers
- 1 April 2006
- journal article
- review article
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 24 (1) , 467-496
- https://doi.org/10.1146/annurev.immunol.24.021605.090517
Abstract
The pathogenic roles of B cells in autoimmune diseases occur through several mechanistic pathways that include autoantibodies, immune complexes, dendritic and T cell activation, cytokine synthesis, chemokine-mediated functions, and ectopic neolymphogenesis. Each of these pathways participate to different degrees in autoimmune diseases. The use of B cell–targeted and B cell subset–targeted therapies in humans is illuminating the mechanisms at work in a variety of human autoimmune diseases. In this review, we highlight some of these recent findings that provide insights into both murine models of autoimmunity and human autoimmune diseases.Keywords
This publication has 173 references indexed in Scilit:
- Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic interventionOncogene, 2005
- The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challengeInternational Immunology, 2004
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004
- Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndromeThe Journal of Pathology, 2004
- Rituximab in the treatment of polyneuropathy associated with anti‐MAG antibodiesMuscle & Nerve, 2003
- Anti-CD40 therapy extends renal allograft survival in rhesus macaques1Transplantation, 2002
- CD154–CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosusArthritis & Rheumatism, 2002
- Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosisPublished by Elsevier ,1999
- CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania majorImmunity, 1996
- Transfusion studies in rheumatoid arthritisArthritis & Rheumatism, 1961